Literature DB >> 28939923

[Thyroid emergencies : Thyroid storm and myxedema coma].

C Spitzweg1, M Reincke2, R Gärtner2.   

Abstract

Thyroid emergencies are rare life-threatening endocrine conditions resulting from either decompensated thyrotoxicosis (thyroid storm) or severe thyroid hormone deficiency (myxedema coma). Both conditions develop out of a long-standing undiagnosed or untreated hyper- or hypothyroidism, respectively, precipitated by an acute stress-associated event, such as infection, trauma, or surgery. Cardinal features of thyroid storm are myasthenia, cardiovascular symptoms, in particular tachycardia, as well as hyperthermia and central nervous system dysfunction. The diagnosis is made based on clinical criteria only as thyroid hormone measurements do not differentiate between thyroid storm and uncomplicated hyperthyroidism. In addition to critical care measures therapy focusses on inhibition of thyroid hormone synthesis and secretion (antithyroid drugs, perchlorate, Lugol's solution, cholestyramine, thyroidectomy) as well as inhibition of thyroid hormone effects in the periphery (β-blocker, glucocorticoids).Cardinal symptoms of myxedema coma are hypothermia, decreased mental status, and hypoventilation with risk of pneumonia and hyponatremia. The diagnosis is also purely based on clinical criteria as measurements of thyroid hormone levels do not differ between uncomplicated severe hypothyroidism and myxedema coma. In addition to substitution of thyroid hormones and glucocorticoids, therapy focusses on critical care measures to treat hypoventilation and hypercapnia, correction of hyponatremia and hypothermia.Survival of both thyroid emergencies can only be optimized by early diagnosis based on clinical criteria and prompt initiation of multimodal therapy including supportive measures and treatment of the precipitating event.

Entities:  

Keywords:  Antithyroid drugs; Critical care, supportive; Glucocorticoids; Hormone replacement therapy; L-Thyroxine; Thyroid hormones

Mesh:

Year:  2017        PMID: 28939923     DOI: 10.1007/s00108-017-0306-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  20 in total

1.  [Immunogenic hyperthyroidism with hyperdynamic heart failure and early cirrhotic transformation of the liver].

Authors:  M R Fischer; C H Spes; R Huss; R Gärtner
Journal:  Dtsch Med Wochenschr       Date:  1997-03-14       Impact factor: 0.628

2.  Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study.

Authors:  Trevor E Angell; Melissa G Lechner; Caroline T Nguyen; Victoria L Salvato; John T Nicoloff; Jonathan S LoPresti
Journal:  J Clin Endocrinol Metab       Date:  2014-10-24       Impact factor: 5.958

3.  Management of thyrotoxic crises with a beta-adrenergic blocking agent (Pronethalol).

Authors:  G Hughes
Journal:  Br J Clin Pract       Date:  1966-11

Review 4.  Life-threatening thyrotoxicosis. Thyroid storm.

Authors:  H B Burch; L Wartofsky
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

5.  Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys.

Authors:  Takashi Akamizu; Tetsurou Satoh; Osamu Isozaki; Atsushi Suzuki; Shu Wakino; Tadao Iburi; Kumiko Tsuboi; Tsuyoshi Monden; Tsuyoshi Kouki; Hajime Otani; Satoshi Teramukai; Ritei Uehara; Yosikazu Nakamura; Masaki Nagai; Masatomo Mori
Journal:  Thyroid       Date:  2012-06-12       Impact factor: 6.568

6.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Authors:  Douglas S Ross; Henry B Burch; David S Cooper; M Carol Greenlee; Peter Laurberg; Ana Luiza Maia; Scott A Rivkees; Mary Samuels; Julie Ann Sosa; Marius N Stan; Martin A Walter
Journal:  Thyroid       Date:  2016-10       Impact factor: 6.568

7.  Superior sagittal sinus thrombosis secondary to hyperthyroidism.

Authors:  A Dai; M Wasay; N Dubey; P Giglio; R Bakshi
Journal:  J Stroke Cerebrovasc Dis       Date:  2000 Mar-Apr       Impact factor: 2.136

Review 8.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

9.  Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan.

Authors:  Yosuke Ono; Sachiko Ono; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi; Yuji Tanaka
Journal:  J Epidemiol       Date:  2017-01-05       Impact factor: 3.211

10.  Predictors of outcome in myxoedema coma: a study from a tertiary care centre.

Authors:  Pinaki Dutta; Anil Bhansali; Shriq Rashid Masoodi; Sanjay Bhadada; Navneet Sharma; Rajesh Rajput
Journal:  Crit Care       Date:  2008-01-03       Impact factor: 9.097

View more
  6 in total

Review 1.  [Hypothyroidism-when and how to treat?]

Authors:  V F Koehler; M Reincke; C Spitzweg
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

2.  Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.

Authors:  Dmytro Oliinyk; Teresa Augustin; Josefine Rauch; Viktoria Florentine Koehler; Claus Belka; Christine Spitzweg; Lukas Käsmann
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-12       Impact factor: 4.322

Review 3.  The Myxedema coma in children and adolescents: A rare endocrine emergency - Personal experience and review of literature.

Authors:  Vincenzo De Sanctis; Ashraf Soliman; Shahina Daar; Salvatore Di Maio; Noora Alhumaidi; Mayam Alali; Aml Sabt; Christos Kattamis
Journal:  Acta Biomed       Date:  2021-11-03

4.  New-Onset Hypothyroidism Manifesting As Myxedema Coma: Fighting an Old Enemy.

Authors:  Andrea Santos Argueta; Sotirios G Doukas; Roopa Roy
Journal:  Cureus       Date:  2022-04-06

5.  Deficiency of Thyroid Hormone Reduces Voltage-Gated Na+ Currents as Well as Expression of Na+/K+-ATPase in the Mouse Hippocampus.

Authors:  Sivaraj Mohana Sundaram; Romy Marx; Heiko M Lesslich; Irmgard D Dietzel
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

6.  ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer.

Authors:  Alexis Vrachimis; Ioannis Iakovou; Evanthia Giannoula; Luca Giovanella
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.